Development of a human live attenuated West Nile infectious DNA vaccine: Identification of a minimal mutation set conferring the attenuation level acceptable for a human vaccine
Effect of mutations in E on properties of WN1806 is determined. A subset of attenuating mutations suitable for a human vaccine is defined. Mechanism of attenuation is proposed and illustrated. Underlying mechanisms of neurovirulence reversion are suggested.